Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Caribou Biosciences (CRBU) FCF Margin: 2020-2025

Historic FCF Margin for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to -1,151.73%.

  • Caribou Biosciences' FCF Margin rose 49521.00% to -1,151.73% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,374.53%, marking a year-over-year decrease of 23512.00%. This contributed to the annual value of -1,431.66% for FY2024, which is 112739.00% down from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' FCF Margin is -1,151.73%, which was down 7.05% from -1,075.85% recorded in Q2 2025.
  • Caribou Biosciences' 5-year FCF Margin high stood at 1,274.78% for Q1 2021, and its period low was -1,732.69% during Q4 2024.
  • For the 3-year period, Caribou Biosciences' FCF Margin averaged around -1,086.52%, with its median value being -1,075.85% (2025).
  • Examining YoY changes over the last 5 years, Caribou Biosciences' FCF Margin showed a top increase of 59,057bps in 2022 and a maximum decrease of 212,515bps in 2022.
  • Over the past 5 years, Caribou Biosciences' FCF Margin (Quarterly) stood at -862.60% in 2021, then skyrocketed by 13,668bps to -725.92% in 2022, then soared by 6,105bps to -664.87% in 2023, then slumped by 106,782bps to -1,732.69% in 2024, then soared by 49,521bps to -1,151.73% in 2025.
  • Its FCF Margin stands at -1,151.73% for Q3 2025, versus -1,075.85% for Q2 2025 and -1,605.06% for Q1 2025.